Dermtech Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2024 to a ratio of 4.4, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the first quarter 2024. Average receivable collection period, for the Dermtech Inc in Mar 31 2024 quarter, has decreased to 83 days, compared to 92 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 513 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2024 from 3272 to 3276.

What is Receivable Turnover Ratio?
What is Dermtech Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DMTK Receivables Turnover Ratio	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Receivable Change	-32.33 %	-38.06 %	-40.91 %	-35.17 %	-26.13 %
Y / Y Revenue Change	6.79 %	31.06 %	-11.22 %	-28.94 %	-6.48 %
Receivable Turnover Ratio (TTM)	4.4	3.95	3.3	2.93	2.87
DMTK's Total Ranking	# 3276	# 3272	# 1280	# 3252	#
Accounts Receivable average collection period days	83	92	111	125	127
Seq. Receivable Change	-3.37 %	-28.32 %	-6.73 %	4.74 %	-11.55 %
Seq. Revenue Change	-5.38 %	23.71 %	5.45 %	-13.49 %	16.13 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 32
Healthcare Sector	# 514
Overall Market	# 3276

Receivable Turnover Ratio Statistics
High	Average	Low
0.13	0.07	0.04
(Jun 30 2020)		(Dec 31 2021)

DMTK Company Profile • Back to DMTK Efficiency Comparisons • Compare DMTK Receivables Turnover Ratio to its Competitors

Financial Statements
Dermtech Inc 's Accounts Receivable	$ 2 Millions	Visit DMTK's Balance sheet
Dermtech Inc 's Sales TTM	$ 14 Millions	Visit DMTK's Income Statement
Sources of DMTK's Revenues		Visit DMTK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DMTK's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DMTK's Growth Rates	DMTK's Roa	DMTK's Inventory Turnover Ratio	DMTK's Dividend Comparisons
DMTK's Profitability Ratios	DMTK's Roi	DMTK's Asset Turnover Ratio	DMTK's Dividend Growth
DMTK's Valuation Ratios	DMTK's Roe	DMTK's Financial Strength Ratios	DMTK's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2024	Receivable at quarter ending Mar 31 2024
Nexalin Technology Inc	15.19	$ 0.159 Millions	$ 0.010 Millions
China Health Industries Holdings Inc	14.34	$ 0.061 Millions	$ 0.004 Millions
Icu Medical Inc	14.31	$ 2,256.721 Millions	$ 157.694 Millions
Ensysce Biosciences Inc	14.23	$ 2.101 Millions	$ 0.148 Millions
Chemed Corporation	14.18	$ 2,293.493 Millions	$ 161.797 Millions
Precipio inc	13.83	$ 15.812 Millions	$ 1.144 Millions
Innovative Eyewear Inc	13.76	$ 1.391 Millions	$ 0.101 Millions
Rosecliff Acquisition Corp I	13.76	$ 19.304 Millions	$ 1.403 Millions
Utah Medical Products Inc	13.74	$ 48.343 Millions	$ 3.518 Millions
Patterson Companies Inc	13.60	$ 6,568.242 Millions	$ 482.794 Millions
Gyre Therapeutics Inc	13.30	$ 115.691 Millions	$ 8.696 Millions
Eyepoint Inc	13.12	$ 50.019 Millions	$ 3.814 Millions
Amylyx Pharmaceuticals Inc	12.92	$ 398.001 Millions	$ 30.807 Millions
Nutriband Inc	12.87	$ 2.017 Millions	$ 0.157 Millions
Inovio Pharmaceuticals Inc	12.74	$ 8.143 Millions	$ 0.639 Millions
Traws Pharma inc	12.73	$ 0.226 Millions	$ 0.018 Millions
Petvivo Holdings Inc	12.57	$ 0.969 Millions	$ 0.077 Millions
International Stem Cell Corporation	12.47	$ 7.832 Millions	$ 0.628 Millions
Exact Sciences Corporation	12.40	$ 2,547.946 Millions	$ 205.482 Millions
Caribou Biosciences Inc	12.35	$ 33.404 Millions	$ 2.704 Millions
Corcept Therapeutics Inc	12.33	$ 523.529 Millions	$ 42.455 Millions
Teladoc Health Inc	12.29	$ 2,619.302 Millions	$ 213.191 Millions
Lifeloc Technologies Inc	12.26	$ 9.318 Millions	$ 0.760 Millions
Lftd Partners Inc	12.01	$ 49.815 Millions	$ 4.149 Millions
Xoma Royalty Corporation	11.91	$ 5.811 Millions	$ 0.488 Millions
Siga Technologies Inc	11.78	$ 157.024 Millions	$ 13.334 Millions
Nrc Health	11.65	$ 147.420 Millions	$ 12.653 Millions
Valion Bio Inc	11.57	$ 1.134 Millions	$ 0.098 Millions
Surmodics Inc	11.57	$ 142.963 Millions	$ 12.360 Millions
Immunoprecise Antibodies Ltd	11.46	$ 18.781 Millions	$ 1.638 Millions

Date modified: 2026-09-08T17:26:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.